Endurant Capital Management LP Argenx Se Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$360.14 - $422.58 $1.29 Million - $1.51 Million
-3,572 Reduced 58.2%
2,565 $999,000
Q1 2023

May 15, 2023
BUY
$334.23 - $403.65 $2.05 Million - $2.48 Million
6,137 New
6,137 $2.29 Million
Q2 2022

Aug 15, 2022
SELL
$269.58 - $378.88 $1.21 Million - $1.7 Million
-4,480 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$254.45 - $351.06 $1.14 Million - $1.57 Million
4,480 New
4,480 $1.41 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email